Isolasi Sel Punca Pluripoten dengan Penanda CD105+ dan SSEA3+ dari Sel Fibroblas Kulit asal Jaringan Preputium
Kata Kunci:
fibroblasts, selpunca CD105 ,, sel punca SSEA3 , alkalin fosfataseAbstrak
The development and knowledge of stem cell research are growing quickly. Stem cells are now likely to become a modern treatment as a regenerative approach that has potential treatment for various diseases that are difficult to cure, such as genetic diseases, degenerative, trauma, and malignancy. The aimed of this study was to isolate pluripotent stem cells using human dermal fibroblast cell obtained from preputium tissue by enzymatic and tissue explants methods, followed by double positive characterization for specific markers of cluster differentiation (CD) 105 and surface-stage embryonic antigen (SSEA)-3 using magnetic-based purification system (MACS). The fibroblast cells resulted from both method were cultured and expanded by variations medium and passage cells, then were characterized for double positive CD 105+ and SSEA3+. Fibroblast cell culturing in conditioned medium, lower passage and higher density has the highest percentage of CD105+ subpopulation cells compared than fibroblast cell in standard medium, higher passage and lower density. Subpopulation of both of CD 105+ and SSEA3+ cells revealed a positive response to alkaline phosphatase dye which proving a population of stem cells.
Referensi
Unduhan
Diterbitkan
Terbitan
Bagian
Lisensi
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

















